Makrogoli Orion (Macrogol 4000)

Makrogoli Orion, an osmotic laxative, is indicated for conditions affecting bowel motility and preparation for diagnostic procedures.

• Constipation: provides soft, easy‑to‑pass stools by retaining water in the colon.
• Bowel preparation for colonoscopy: clears the intestinal tract to improve visualization during the procedure.
• Chronic constipation in adults: supports regular bowel movements when lifestyle measures are insufficient.

• Macrogol 4000 is a high‑molecular‑weight polymer that is not absorbed from the gastrointestinal tract. It exerts its laxative effect by creating an osmotic gradient that draws water into the intestinal lumen, increasing stool volume and softness. The resulting distension stimulates peristalsis, promoting the transit of fecal matter through the colon. The polymer remains in the gut until eliminated, providing a sustained osmotic action throughout the colon.

Macrogol 4000 may cause a range of gastrointestinal and systemic reactions, most of which are mild and transient. Patients should be aware of possible reactions and monitor their symptoms during treatment. Common side effects are typically mild, occur shortly after the first dose, and resolve without medical intervention.

Common Side Effects

• Abdominal bloating
• Flatulence
• Nausea
• Mild abdominal cramps
• Diarrhea
• Increased thirst

Serious or Rare Side Effects

• Severe dehydration
• Electrolyte imbalance (e.g., low potassium)
• Allergic reactions such as rash or angioedema
• Intestinal obstruction
• Severe abdominal pain

When using Makrogoli Orion, certain precautions help ensure safe and effective therapy.

• Assess hydration status: confirm the patient is adequately hydrated before initiating therapy.
• Encourage fluid intake: advise regular consumption of water to support the osmotic action.
• Avoid in known hypersensitivity: discontinue if allergic reactions such as rash develop.
• Contraindicated in intestinal perforation: do not use in patients with known bowel perforation or obstruction.
• Use caution in renal impairment: monitor renal function as fluid shifts may affect electrolyte balance.
• Store at room temperature: keep in the original packaging, protect from moisture and excessive heat.

Macrogol 4000 can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid)

• Other osmotic laxatives: combined use may cause severe electrolyte disturbances.
• Loop diuretics: increased risk of dehydration and electrolyte loss.
• Mineral oil: may reduce the effectiveness of both agents and increase risk of impaction.
• Anticholinergic agents: may diminish the laxative effect.

Moderate Interactions (Monitor Closely)

• NSAIDs: concurrent use may increase gastrointestinal irritation.
• Antacids: could alter the intestinal environment, affecting drug performance.
• Oral rehydration solutions: monitor fluid balance to avoid over‑correction.